MAJOR — Use With Caution
Tianeptine and SSRIs/SNRIs — Major Interaction (Serotonin Syndrome Risk)
Evidence level: STRONG
RISKY COMBINATION. Desvenlafaxine is the active metabolite of venlafaxine and inhibits serotonin and norepinephrine reuptake with minimal CYP450 interactions. While its cleaner metabolic profile reduces drug interaction complexity compared to venlafaxine, the core danger remains: combining its serotonin reuptake inhibition with tianeptine's serotonergic and opioid activity creates serious serotonin syndrome risk.
Tianeptine modulates serotonin reuptake (originally classified as a selective serotonin reuptake enhancer, though this mechanism is debated) and has mu-opioid agonist activity. SSRIs/SNRIs inhibit serotonin reuptake. The combined serotonergic effects create risk of serotonin syndrome. Additionally, tianeptine's opioid activity combined with tramadol-like properties of some SNRIs compounds the danger.
Do not combine tianeptine with Desvenlafaxine (Pristiq). Although desvenlafaxine has fewer drug-drug interactions than its parent compound venlafaxine (because it bypasses CYP2D6 metabolism), the serotonin syndrome risk with tianeptine is just as real. Desvenlafaxine has a half-life of about 11 hours; allow at least 5 days washout before starting tianeptine. It comes in extended-release tablets that should never be crushed or split. Seek emergency help for tremor, hyperthermia, or mental status changes.
Take Desvenlafaxine as prescribed. Tianeptine can typically be taken with a meal, spaced 1-2 hours from the medication for clean absorption. Discuss this combination with your pharmacist for personalized guidance.
Higher risk for: elderly, those on multiple serotonergic drugs, people with liver impairment, CYP2D6 poor metabolizers, recent dose changes, or concurrent use of MAOIs or triptans.
Agitation, restlessness, rapid heart rate, dilated pupils, muscle twitching or rigidity, high body temperature, sweating, diarrhea, confusion. Seek emergency care if these develop.
Disclose tianeptine use to your prescriber. Discuss serotonin syndrome risk. Tianeptine is not approved in the US and has significant abuse potential via its opioid activity. Explore safer antidepressant monotherapy options.
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
RISKY COMBINATION. Desvenlafaxine is the active metabolite of venlafaxine and inhibits serotonin and norepinephrine reuptake with minimal CYP450 interactions. While its cleaner metabolic profile reduces drug interaction complexity compared to venlafaxine, the core danger remains: combining its serotonin reuptake inhibition with tianeptine's serotonergic and opioid activity creates serious serotonin syndrome risk.
Take Desvenlafaxine as prescribed. Tianeptine can typically be taken with a meal, spaced 1-2 hours from the medication for clean absorption. Discuss this combination with your pharmacist for personalized guidance.
Agitation, restlessness, rapid heart rate, dilated pupils, muscle twitching or rigidity, high body temperature, sweating, diarrhea, confusion. Seek emergency care if these develop.
Discuss this combination with your prescriber. They may adjust timing, dosing, or switch to an alternative with fewer interaction risks. Never stop an antidepressant abruptly — taper under medical guidance.
Disclose tianeptine use to your prescriber. Discuss serotonin syndrome risk. Tianeptine is not approved in the US and has significant abuse potential via its opioid activity. Explore safer antidepressant monotherapy options.
Or browse the full interaction database (121,000+ pairs).